SCHEMBL25815695

SCHEMBL25815695

CCOCCCCOc1cccc(C(O)CCN)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
CYP2C19 P33261 1/20 0.46
HIF1A Q16665 1/20 0.46
GMNN O75496 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
ALOX5 P09917 1/20 0.46
HPGD P15428 1/20 0.46
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
MTOR P42345 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25815696 0.99 MAPK1 (0.45) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL4572157 0.91 MAPK1 (0.50) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL29818747 0.89 CYSLTR2 (0.56) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL19291629 0.89 CYSLTR2 (0.56) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL2207435 0.89 CYSLTR2 (0.56) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL19291557 0.88 TSHR (0.55) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL16084812 0.88 LTB4R (0.52) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL29819323 0.86 AOC3 (0.46) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL2203760 0.86 AOC3 (0.46) MAPK1MEN1KMT2ATP53CYP1A2
SCHEMBL25819978 0.86 KMT2A (0.47) MAPK1MEN1KMT2ATP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ALDH1A2, CLN6, AGER MAPK1 2460/4885MEN1 4640/4885KMT2A 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.